De SilvaTI, PostFA, GriffinMD, DockellDH. HIV-1 infection and the kidney: an evolving challenge in HIV medicine. Mayo Clin Proc2007;82:1103–16
2.
FuxCA, SimcockM, FurnerH, Tenofovir use is associated with a reduction in calculated glomerular filtration rates in the Swiss HIV Cohort Study. Antivir Ther2007;12:1165–73
3.
GuptaSK, EustaceJA, SzczechLA, Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infec Dis2005;40:1559–85
4.
WoodwardCLN, JohnsonMA, ConnollyJO, Tenofovir-associated renal and bone toxicity. HIV Med2009;10:482–87
5.
MooreDJ, RoshAJ. Hypophosphatemia: treatment & medication [Online]. 2009?;[4 screens]. See http://emedicine.medscape.com/article/767955-overview (last checked 22 September 2009)
6.
DaySL, Leake DateHA, BannisterA, HankinsM, FisherM. Serum hypophosphatemia in tenofovir disoproxil fumarate recipients is multifactorial in origin, questioning the utility of its monitoring in clinical practice. JAIDS2005;38:301–4
